Back to results
CompletedPhase 1

Safety and Tolerability Study Evaluating ACR325 in Parkinson's Disease Patients

NCT01023282

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Paracelsus-Elena-Klinik

Kassel, Hesse, Germany

+1 additional location

View on ClinicalTrials.gov
Safety and Tolerability Study Evaluating ACR325 in Parkinson's Disease Patients — TrialFind